B Group Inc’s Akero Therapeutics AKRO Stock Holding History

B Group Inc’s Portfolio AKRO Stock Details AKRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-232,446	Closed	-$11M	–	17
2025 Q3	$11M	Hold	232,446	–	–	8.12%	5
2025 Q2	$12.4M	Sell	232,446 -10,054	-4%	-$457K	9.55%	4
2025 Q1	$9.82M	Sell	242,500 -17,500	-7%	-$742K	8.41%	4
2024 Q4	$7.23M	Buy	+260,000	New	+$7.87M	4.42%	6

Other funds holding AKRO

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

B Group Inc's AKRO Position: Q4 2025 in Review

B Group Inc sold out of Akero Therapeutics (AKRO) in Q4 2025, closing a stake of 232,446 shares — an estimated $11M sold.

B Group Inc first reported a position in AKRO in Q4 2024 and held it in 4 quarters. The position peaked at $12.4M in Q2 2025. 2 funds tracked by Wall St. Rank hold AKRO as of Q4 2025.

B Group Inc reported no remaining Akero Therapeutics position as of Q4 2025 after selling out during the quarter.
B Group Inc sold 232,446 Akero Therapeutics shares in Q4 2025, an estimated $11M.
B Group Inc first reported a position in Akero Therapeutics in Q4 2024 and held it in 4 quarters.
B Group Inc's Akero Therapeutics position peaked at $12.4M in Q2 2025.
2 funds tracked by Wall St. Rank held Akero Therapeutics as of Q4 2025.

Based on B Group Inc's 13F filing for Q4 2025, filed 17 Feb 2026.